EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prognostic impact of lesser curvature lymph node count in stage I/II gastric cancer: A retrospective study

Pei-Feng Chen, Jia-Jun Qian, Lei Zhang, Zhang-Ming Chen, Wen-Xiu Han

World Journal of Gastrointestinal Oncology · 2026-11-15 · 18 (11)

DOI: 10.4251/wjgo.123356 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Current lymph node (LN) staging for gastric cancer relies primarily on total LN count. The number of LNs retrieved from specific anatomical regions may carry additional prognostic value. AIM To evaluate the prognostic impact of the lesser curvature LN count in patients with clinical stage I/II gastric cancer. METHODS A total of 254 patients with clinical stage I/II lesser curvature gastric adenocarcinoma who underwent curative total gastrectomy with D2 lymphadenectomy were retrospectively analyzed. The optimal cutoff was identified using a systematic threshold-searching approach based on the log-rank test and univariate Cox regression. This threshold was further assessed in key pathological subgroups and evaluated in multivariate Cox models adjusted for established prognostic factors. RESULTS The retrieval of ≤ 7 lesser curvature LNs was identified as the optimal cutoff, independently associated with worse overall survival (hazard ratio = 2.37, 95% confidence interval: 1.44-3.90, P = 0.0005). This prognostic significance was consistently validated in key subgroups including node-negative (N0), node-positive (N+), and T3 patients. In multivariate analysis, ≤ 7 lesser curvature LNs remained an independent adverse prognostic factor after adjusting for age, T stage, N stage, lymphovascular invasion, and perineural invasion (hazard ratio = 2.20, 95% confidence interval: 1.27-3.82, P = 0.005). CONCLUSION In this study, a lesser curvature LN count of ≤ 7 was associated with poorer overall survival, suggesting a potential risk of stage migration.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →